Cricket Health, a San Francisco, CA- and Cambridge, MA-based provider of value-based kidney care, closed an $83.5m Series B funding round.
The round was led by Valtruis with participation from existing investors Oak HC/FT and Cigna Ventures, as well as K2 HealthVentures and a strategic investment from Blue Shield of California.
The company intends to use the funds for rapid expansion to support demand for its care model for people with kidney disease across the United States.
Founded in 2015 and led by Robert Sepucha, CEO, Cricket Health is a provider of value-based kidney care with a clinically-proven approach to managing chronic kidney disease (CKD) and end-stage kidney disease (ESKD).
Through its StageSmart™ predictive analytics model, Cricket Health is able to identify patients with chronic kidney disease in stage 3b and beyond with 96 percent accuracy. This allows the company to risk stratify patient populations for plans and providers, and deliver stage-specific care to those who need it most. Cricket Health extends care delivery capabilities through the MyCricket™ comprehensive patient support service, which includes a multidisciplinary care team, peer support, and educational resources available any time virtually, as well as by telephone or in person when needed. If patients do progress to end-stage kidney disease (ESKD), the company’s evidence-based approach increases transplant referrals, increases utilization of home dialysis, and reduces unnecessary hospitalizations.
With the new funding, Cricket Health has raised a total of more than $120 million in equity and debt financing to date.